In Conversation With Wynand Claassens, The Vapour Products Association of South Africa (VPASA) (Chairman).
Loading player...
South Africa is currently at a critical policy crossroads with the proposed Tobacco Products and Electronic Delivery Systems Control Bill, which aims to significantly tighten regulations on tobacco and nicotine-related products. The Bill—first introduced in 2022 and now advancing after extensive public hearings—seeks to align South Africa with global public health standards, including those of the World Health Organization.
At its core, the legislation proposes stricter measures such as plain packaging, bans on advertising and product display, expanded smoke-free zones, and tighter regulation of emerging products like e-cigarettes and vaping devices.
However, what has made this Bill particularly contentious is the debate around harm reduction. Public health advocates argue that all nicotine products—whether cigarettes or alternatives like vapes—should be tightly controlled due to their addictive nature and long-term health risks. On the other hand, some researchers, industry stakeholders, and advocacy groups argue that non-combustible alternatives may present a lower-risk option for smokers trying to quit, and should therefore be regulated differently rather than treated the same as traditional tobacco.
This has created a sharp policy divide:
• Public health vs economic impact – Concerns about the livelihoods of small traders and informal businesses reliant on tobacco sales
• Regulation vs unintended consequences – Fears that strict controls (like plain packaging) could fuel illicit trade
• Science vs policy interpretation – Ongoing disagreement on whether harm reduction strategies are sufficiently evidence-based
Youth protection remains central to the Bill. Lawmakers and public health groups have raised alarm over the rising popularity of vaping among young people, arguing that regulation is necessary to prevent a new generation from nicotine addiction.
At the same time, critics argue that policy may be outpacing science, especially where there is no clear differentiation between high-risk and lower-risk products. The question then becomes:
Is South Africa pursuing a prohibition-style model, or a balanced harm-reduction framework?
This moment—post public hearings—marks a crucial phase where Parliament must reconcile conflicting evidence, economic realities, and public health priorities before the Bill is finalised.
At its core, the legislation proposes stricter measures such as plain packaging, bans on advertising and product display, expanded smoke-free zones, and tighter regulation of emerging products like e-cigarettes and vaping devices.
However, what has made this Bill particularly contentious is the debate around harm reduction. Public health advocates argue that all nicotine products—whether cigarettes or alternatives like vapes—should be tightly controlled due to their addictive nature and long-term health risks. On the other hand, some researchers, industry stakeholders, and advocacy groups argue that non-combustible alternatives may present a lower-risk option for smokers trying to quit, and should therefore be regulated differently rather than treated the same as traditional tobacco.
This has created a sharp policy divide:
• Public health vs economic impact – Concerns about the livelihoods of small traders and informal businesses reliant on tobacco sales
• Regulation vs unintended consequences – Fears that strict controls (like plain packaging) could fuel illicit trade
• Science vs policy interpretation – Ongoing disagreement on whether harm reduction strategies are sufficiently evidence-based
Youth protection remains central to the Bill. Lawmakers and public health groups have raised alarm over the rising popularity of vaping among young people, arguing that regulation is necessary to prevent a new generation from nicotine addiction.
At the same time, critics argue that policy may be outpacing science, especially where there is no clear differentiation between high-risk and lower-risk products. The question then becomes:
Is South Africa pursuing a prohibition-style model, or a balanced harm-reduction framework?
This moment—post public hearings—marks a crucial phase where Parliament must reconcile conflicting evidence, economic realities, and public health priorities before the Bill is finalised.
